Researchers at the University of Louisville School of Medicine are using breath analysis to detect the presence of lung cancer.
Preliminary data indicate that this promising noninvasive tool offers the sensitivity of PET scanning, and has almost twice the specificity of PET for distinguishing patients with benign lung disease from those with early stage cancer. Michael Bousamra II, MD, Associate Professor, Department of Cardiovascular and Thoracic Surgery, is presenting the results of the study at the AATS 2014 Conference on April 29, 2014.
A reliable, noninvasive diagnostic method imposes less physical and financial burden on patients who actually have no significant disease, while rapid and accurate diagnosis expedites treatment for patients who truly have lung cancer.
The team believes that while the breath test would not replace CT as a primary screening tool, it would be particularly helpful in conjunction with a positive CT scan result. “This breath analysis method presents the potential for a cheaper and more reliable diagnostic option for patients found to have bulky disease on a CT scan. If the breath analysis is negative, the patient may, in some instances, be followed with repeated exams without necessitating a biopsy. But a positive breath analysis would indicate that the patient may proceed to definitive biopsy, thus expediting treatment,” says Dr. Bousamra.
Investigators used specially coated silicon microchips to collect breath samples from 88 healthy controls, 107 patients with lung cancer, 40 individuals with benign pulmonary disease, and 7 with metastatic lung cancer.
Previous work had pinpointed four specific substances, known as carbonyl compounds, in breath samples as “elevated cancer markers” (ECMs) that distinguish patients with lung cancer from those with benign disease. The carbonyl compounds found in the breath are thought to reflect chemical reactions occurring in malignant lung tumors. In this study, the authors compared the findings from the breath analyses to the results from PET scans.
The investigators found that the sensitivity and specificity of breath analysis depended upon how many of the ECMs were elevated. For example, having 3 or 4 ECMs was diagnostic of lung cancer in 95% of those with this result. The majority of patients with benign pulmonary disease had either 0 or 1 ECM, while those with Stage IV cancer were most likely to have 3 or 4. The number of ECMs could be used to differentiate benign disease from both early and advanced stage lung cancer. Interestingly, 3 of the 4 elevated markers returned to normal levels after cancer resection.
When it comes to differentiating early stage lung cancer from benign pulmonary disease, breath analysis and PET scanning had similar sensitivities (82.8% and 90.3%, respectively). However, breath analysis had a much higher specificity than PET (75% vs. 38.7%, respectively) for distinguishing benign disease, which means that it was much more accurate at identifying those who did not have cancer. This would be an important feature for patients with benign disease, since having a breath analysis rather than PET scan could mean avoiding an unnecessary invasive biopsy procedure later on.
The Latest on: Detect Early Lung Cancer
via Google News
The Latest on: Detect Early Lung Cancer
- National Breast Cancer Month: Early detection is vital to protecting your healthon October 12, 2020 at 8:53 am
October is Breast Cancer Awareness Month, which raises awareness about risks and signs, as well as methods for diagnosing during more treatable stages.
- Jacksonville Nurse Named National Lung Cancer Heroon October 8, 2020 at 12:03 pm
One of your neighbors posted in Health & Fitness. Click through to read what they have to say. (The views expressed in this post are the author’s own.) ...
- B.C. launches early detection lung cancer screening – the first in Canadaon October 6, 2020 at 11:45 am
British Columbians at high risk of lung cancer will soon be able to receive early detection screening through a new lung cancer screening program offered by BC Cancer – the first of its kind in Canada ...
- Metro Health launches robot technology for early diagnosis of lung canceron October 5, 2020 at 7:04 am
University of Michigan Health is pioneering the use of an advanced robotic system to diagnose lung cancer at the earliest, hardest-to-reach stages.
- Hope for lung cancer patientson October 4, 2020 at 9:13 am
According to the 2018 report of the World Cancer Research Fund, lung cancer is the second most common cancer in men and third most commonly occurring cancer in women. Globally, there were 2.1 million ...
- Binghamton University professor creates prototype tool to detect lung canceron October 2, 2020 at 5:03 pm
Jian "CJ" Zhong, a chemistry Professor at Binghamton University, has created a device to help detect lung cancer just by breathing into a tube. Zhong, a specialist in sensors, said he is still in the ...
- Don’t put off cancer screenings delayed by COVID-19 – early detection saves liveson October 2, 2020 at 9:17 am
The data are clear – early detection saves lives, and the time to resume cancer screening is now. The National Cancer Institute recently projected 10,000 additional deaths in the United States due to ...
- Metro Health adds robotic technology for early lung cancer detectionon September 30, 2020 at 5:51 pm
University of Michigan Health, as a part of the Cancer Network of West Michigan, is pioneering the use of robotic technology to diagnose lung cancer earlier. The Grand Rapids-area health system’s use ...
- Why early detection research can’t wait: we hear from the experts in our latest virtual eventon September 21, 2020 at 7:46 am
She’s developing blood tests to improve our ability to detect lung cancer at an earlier stage. “What we’ve found with lung cancer quite recently is that, even in early stage-one cancers, some cells ...
- Universal Diagnostics Presents New Promising Data on Early (Pre) Cancer Detection from Cell Free DNA at European Society for Medical Oncology (ESMO)on September 21, 2020 at 1:38 am
“Building on encouraging preliminary data in colorectal cancer and adenomas, the data presented at ESMO 2020 suggests that the UDX test may also have an application in the early detection of ...
via Bing News